Receptor recognition by gp130 cytokines

被引:165
作者
Bravo, J
Heath, JK [1 ]
机构
[1] Univ Birmingham, CRC, Growth Factor Grp, Sch Biosci, Birmingham B15 2TT, W Midlands, England
[2] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
cytokines; gp130; receptor recognition epitopes; receptor signalling complexes;
D O I
10.1093/emboj/19.11.2399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokines of the gp130 family exert their diverse biological effects by formation of stable high affinity transmembrane receptor complexes that are characterized by the presence of the shared transmembrane signalling receptor gp130. Different gp130 ligands form signalling complexes that vary in both composition and stoichiometry. Analysis of the three-dimensional structure of selected ligands and receptor elements indicates that ligands display three topologically conserved receptor recognition epitopes that interact with complementary ligand recognition elements. The composition of the signalling complex and downstream biological responses is defined by the relative affinity of different receptor components for these epitopes. The detailed structure of receptor recognition epitopes indicates that the generation of small molecule cytokine mimetics may be a feasible objective.
引用
收藏
页码:2399 / 2411
页数:13
相关论文
共 119 条
  • [101] SIGNALING MECHANISMS THROUGH CYTOKINE RECEPTORS THAT SHARE SIGNAL-TRANSDUCING RECEPTOR COMPONENTS
    TAGA, T
    KISHIMOTO, T
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (01) : 17 - 23
  • [102] Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains
    Taupin, JL
    Miossec, V
    Pitard, V
    Blanchard, F
    Daburon, S
    Raher, S
    Jacques, Y
    Godard, A
    Moreau, JF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) : 14482 - 14489
  • [103] A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor
    Tian, SS
    Lamb, P
    King, AG
    Miller, SG
    Kessler, L
    Luengo, JI
    Averill, L
    Johnson, RK
    Gleason, JG
    Pelus, LM
    Dillon, SB
    Rosen, J
    [J]. SCIENCE, 1998, 281 (5374) : 257 - 259
  • [104] 3 DIFFERENT CDNAS ENCODING MOUSE D-FACTOR/LIF RECEPTOR
    TOMIDA, M
    YAMAMOTOYAMAGUCHI, Y
    HOZUMI, M
    [J]. JOURNAL OF BIOCHEMISTRY, 1994, 115 (03) : 557 - 562
  • [105] Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity
    Toniatti, C
    Cabibbo, A
    Sporeno, E
    Salvati, AL
    Cerretani, M
    Serafini, S
    Lahm, A
    Cortese, R
    Ciliberto, G
    [J]. EMBO JOURNAL, 1996, 15 (11) : 2726 - 2737
  • [106] An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M
    Vernallis, AB
    Hudson, KR
    Heath, JK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) : 26947 - 26952
  • [107] CRYSTAL-STRUCTURE OF A COMPLEX BETWEEN INTERFERON-GAMMA AND ITS SOLUBLE HIGH-AFFINITY RECEPTOR
    WALTER, MR
    WINDSOR, W
    NAGABHUSHAN, TL
    LUNDELL, DJ
    LUNN, CA
    ZAUODNY, PJ
    NARULA, SK
    [J]. NATURE, 1995, 376 (6537) : 230 - 235
  • [108] WARD LD, 1994, J BIOL CHEM, V269, P23286
  • [109] Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6 receptor complex
    Ward, LD
    Hammacher, A
    Howlett, GJ
    Matthews, JM
    Fabri, L
    Moritz, RL
    Nice, EC
    Weinstock, J
    Simpson, RJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) : 20138 - 20144
  • [110] WARE CB, 1995, DEVELOPMENT, V121, P1283